Insulet CFO McMillan Steps Down to Join 3M Health Care Business
By Ben Glickman
Insulet Corp. Chief Financial Officer Wayde McMillan will step down to join 3M's Health Care business, which will be spun off.
The Acton, Mass.-based tubeless insulin pump maker said Tuesday McMillan would step down Oct. 20 and would be succeeded by Chief Accounting Officer Lauren Budden on an interim basis. She previously served as accounting chief at privately held Gulf Oil.
Budden joined Insulet in April 2019, according to the company. A search for a permanent successor to McMillan has begun.
McMillan is the latest hire for the soon to be separated healthcare spinoff. 3M named Bryan Hanson, an executive from musculoskeletal company Zimmer Biomet Holdings, as chief executive of the new business in August. Healthcare industry veteran Carrie Cox will become chairman.
Write to Ben Glickman at ben.glickman@wsj.com
(END) Dow Jones Newswires
October 03, 2023 16:53 ET (20:53 GMT)
Copyright (c) 2023 Dow Jones & Company, Inc.-
What’s Happening in the Markets This Week
-
Worst-Performing Stock ETFs of the Quarter
-
Q3 in Review and Q4 2024 Market Outlook
-
Top-Performing Stock ETFs of the Quarter
-
September Jobs Report Forecasts Show Moderate Hiring Gains
-
Port Strike a Headache for Shippers but a Potential Tailwind for Certain US Transport Stocks
-
13 Charts on Q3′s Roller-Coaster Rally for Stocks and Bonds
-
5 Stocks to Buy Instead of Overpriced US Equities
-
Consumer Defensives: Despite Angst, Thirsty Investors Have Names to Pursue
-
Industrials: Many Stocks Overvalued After Q3 Outperformance
-
Basic Materials: Despite Index Rise, We See Multiple Long-Term Opportunities
-
What the Election Could Mean for Big Tech Stocks
-
3 Lessons From Recent Stock Market Drama
-
Consumer Cyclicals: Even Amid Moderating Consumer Spending, We See Discounts
-
Healthcare: Valuations Look Fair Overall, With Select Industries Still Undervalued
-
Utilities: Falling Interest Rates, Growth Outlook Boosting Stocks